BOX 74-1 Causes of Carnitine Deficiency Dietary deficiency of the precursor amino acids lysine and methionine Deficiency of any cofactor (e.g., iron, ascorbic acid, pyridoxine, niacin) required by the enzymes of the lysine to carnitine pathway Genetic defect of carnitine biosynthesis Defective intestinal absorption of carnitine Liver or kidney dysfunction that impairs carnitine synthesis Increased metabolic losses of carnitine due to catabolism, impaired tubular resorption, or genetic defect Defective transport of carnitine from tissues of synthesis to tissues where it is maximally used Increased carnitine requirement due to a high-fat diet, drugs (e.g., valproic acid), metabolic stress, or disease Carnitine deficiency states have been classified into two major groups: Diagnosis of systemic carnitine deficiency can be made using serum or 24-hour urine samples
Treatment with immunosuppressive agents may be required
NAC (precursor of glutathione)
This can be helpful for: Individuals with a history of GI sensitivity Those who experienced significant side effects with other GLP-1 medications People who prefer the most cautious approach possible Note: The 1mg starting dose is a community preference, not a clinical trial protocol
Oxidized LDLs play crucial roles in initiating and amplifying inflammatory responses at lesion sites, promoting leukocyte recruitment, and contributing to atherosclerosis progression through vascular smooth muscle cell activation and reduced nitric oxide bioavailability